معرفی
Mario Bigioni is a Professor of Pharmacology at UniCamillus with over 30 years of experience in cancer drug research and innovative therapies for solid and hematological tumors. He holds a PhD in Body Districts Physiology from Tor Vergata University of Rome and a Master’s Degree in Human Nutrition Sciences (LM-61) from the same institution. His career combines academic contributions, editorial roles in international journals, and authorship of pharmaceutical patents and 50+ scientific publications.
Education
- Graduated in Pharmacy
- Residency in Pharmacology, La Sapienza University of Rome
- Master’s Degree in Human Nutrition Sciences, Tor Vergata University of Rome
- PhD in Body Districts Physiology, Tor Vergata University of Rome
Research and Expertise
Dr. Bigioni’s work focuses on pharmacological approaches to oncology, including drug development for cancer therapies. His research spans both solid tumors and hematological malignancies, with a secondary interest in human nutrition sciences.
Professional Affiliations
- Member of American Association for Cancer Research (AACR)
- Member of European Association for Cancer Research (EACR)
Additional Contributions
He has authored and co-authored multiple pharmaceutical patents and over 50 publications in international scientific journals. Dr. Bigioni also serves on the editorial boards of several international journals.
